Rofecoxib for Osteoarthritis and Pain
Rofecoxib, a selective COX-2 inhibitor, has been approved by the FDA for treatment of osteoarthritis, acute pain and menstrual pain....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Rofecoxib for Osteoarthritis and Pain
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1056
Article Code: 1056a
Date: July 2, 1999
Volume: 41
Pages: 59-62
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1056
Article Code: 1056a
Date: July 2, 1999
Volume: 41
Pages: 59-62
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)